Madrigal Pharmaceuticals CFO, Executives Sell Shares in March 2026

Madrigal Pharmaceuticals, Inc. [MDGL] announced that EVP and CFO Dier Mardi sold 80 shares at $435.32/share on March 6, 2026, 40 shares at $425.08/share on March 6, 2026, 160 shares at $434.2/share on March 6, 2026, 646 shares at $431.94/share on March 6, 2026, 116 shares at $432.56/share on March 6, 2026, 40 shares at $437.65/share on March 6, 2026, 80 shares at $427.85/share on March 6, 2026, 420 shares at $426.86/share on March 6, 2026, 120 shares at $430.9/share on March 6, 2026, 40 shares at $429.58/share on March 6, 2026, 160 shares at $429/share on March 6, 2026, 80 shares at $436.69/share on March 6, 2026. Additionally, Chief Commercial Officer Huntsman Carole sold 419 shares at $431.94/share on March 6, 2026, General Counsel Kelley Shannon T sold 360 shares at $431.94/share on March 6, 2026, Director, President and CEO Sibold William John sold 1663 shares at $431.94/share on March 6, 2026, and Director Taub Rebecca sold 491 shares at $431.94/share on March 6, 2026.